Eli Lilly and Company is spending up to $3.8 billion to buy three vaccine makers, supercharging its push into the immunology space. Lilly has agreed to acquire Curevo Vaccine, owner of a midstage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results